News Items

With $50 million from a private foundation, Phoenix-based Barrow Neurological Institute announced Monday that it is opening a center to focus on improving brain-cancer outcomes through experimental clinical trials.

Barrow Neurological Institute, has launched a “phase zero” study that aims to rapidly test drugs on patients whose brain cancer tumors have returned after standard treatment.